Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Noninduction Therapies for Multiple Sclerosis [Article] Peter Alping, Joachim Burman, Jan Lycke, Thomas Frisell, and Fredrik Piehl Neurology - March 2021